Genesis HealthCare to Sell Home & Hospice Operations
|
By HospiMedica International staff writers Posted on 27 Mar 2016 |
|
Genesis HealthCare (Kennett Square, PA, USA) has signed an agreement to sell the majority of its home health and hospice operations to Compassus (Brentwood, TN, USA) for USD 84 million.
The Genesis home health and hospice operations included in the deal are located in the states of California, Idaho, Montana, and New Mexico; remaining hospice operations in Arizona and Nevada will be closed. The agreement is part of an ongoing strategic move launched by Genesis to monetize non-strategic assets, including the home health and hospice businesses, in order to repay debts. The strategy is expected to yield a cash flow income of USD 100–150 million, after tax.
The home health and hospice operations became part of Genesis HealthCare following its February 2015 merger with Skilled Healthcare, which created one of the largest post-acute care providers in the United States. The buyer, Compassus, is comprised of a nationwide network of community-based post-acute care services primarily focused on hospice, palliative, and home health care. The company opened its first hospice in 1979, and following the deal will operate more than 165 programs in 30 states.
“Home health and hospice services are non-strategic businesses for Genesis to operate at this time, and we believe we can better allocate the capital by de-levering our balance sheet,” said George Hager, Jr., CEO of Genesis HealthCare. “We are pleased that our home health and hospice businesses will join a respected, quality provider like Compassus.”
“We are excited to welcome Genesis’ home health and hospice businesses to the Compassus family, as we share very similar missions and values,” said James Deal, CEO of Compassus. “As Compassus continues to grow, this further strengthens our ability and desire to provide greater access to a continuum of high-quality post-acute care, including hospice, palliative, and home health care services to even more patients, families and the health care professionals who serve them.”
According to the Wall Street Journal (WSJ), the supersizing of the healthcare industry in the United States is a result of the Affordable Care Act, and reflects the efforts of providers to gain the scale necessary to succeed amid the changes unleashed or accelerated by the health law. Those include growing pressures to constrain costs and new forms of payment that require providers to meet efficiency and care-quality goals. The process has so far not been slowed down by the growing regulatory concern about health-care consolidation.
Related Links:
Genesis HealthCare
Compassus
The Genesis home health and hospice operations included in the deal are located in the states of California, Idaho, Montana, and New Mexico; remaining hospice operations in Arizona and Nevada will be closed. The agreement is part of an ongoing strategic move launched by Genesis to monetize non-strategic assets, including the home health and hospice businesses, in order to repay debts. The strategy is expected to yield a cash flow income of USD 100–150 million, after tax.
The home health and hospice operations became part of Genesis HealthCare following its February 2015 merger with Skilled Healthcare, which created one of the largest post-acute care providers in the United States. The buyer, Compassus, is comprised of a nationwide network of community-based post-acute care services primarily focused on hospice, palliative, and home health care. The company opened its first hospice in 1979, and following the deal will operate more than 165 programs in 30 states.
“Home health and hospice services are non-strategic businesses for Genesis to operate at this time, and we believe we can better allocate the capital by de-levering our balance sheet,” said George Hager, Jr., CEO of Genesis HealthCare. “We are pleased that our home health and hospice businesses will join a respected, quality provider like Compassus.”
“We are excited to welcome Genesis’ home health and hospice businesses to the Compassus family, as we share very similar missions and values,” said James Deal, CEO of Compassus. “As Compassus continues to grow, this further strengthens our ability and desire to provide greater access to a continuum of high-quality post-acute care, including hospice, palliative, and home health care services to even more patients, families and the health care professionals who serve them.”
According to the Wall Street Journal (WSJ), the supersizing of the healthcare industry in the United States is a result of the Affordable Care Act, and reflects the efforts of providers to gain the scale necessary to succeed amid the changes unleashed or accelerated by the health law. Those include growing pressures to constrain costs and new forms of payment that require providers to meet efficiency and care-quality goals. The process has so far not been slowed down by the growing regulatory concern about health-care consolidation.
Related Links:
Genesis HealthCare
Compassus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Absorbable Monofilament Mesh
Phasix Mesh
New
High-Precision QA Tool
DEXA Phantom
Latest Business News
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- Boston Scientific Acquires Medical Device Company SoniVie
- 2026 World Hospital Congress to be Held in Seoul
- Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
- Philips and Mass General Brigham Collaborate on Improving Patient Care with Live AI-Powered Insights
- Arab Health 2025 Celebrates Landmark 50th Edition
- Boston Scientific Acquires Medical Device Company Intera Oncology
- MEDICA 2024 to Highlight Hot Topics of MedTech Industry
- Start-Ups To Once Again Play Starring Role at MEDICA 2024
- Boston Scientific to Acquire AFib Ablation Company Cortex
- Hologic Acquires Gynesonics to Strengthen Existing Gynecological Surgical Business
- Smith+Nephew and JointVue Partner on Ultrasound Preoperative Planning in Robotics-Assisted Surgery
- Stryker Completes Acquisition of NICO Corporation
Channels
Critical Care
view channel
Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
For individuals with Type 1 diabetes, hypoglycemia (low blood sugar) presents a life-threatening threat, particularly when glucose levels drop too low, which can result in seizures, coma, or even death.... Read more
New Prostate Screening Device Could Replace Traditional Examination Method
Prostate cancer is a leading health concern, with one in seven men being diagnosed with the disease. Early detection is critical for improving patient outcomes, but traditional diagnostic methods, such... Read more
Surgical Techniques
view channel
Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
